Fatores preditivos de resposta a azatioprina em pacientes com doença de Crohn suboclusiva

Loading...
Thumbnail Image

Journal Title

Journal ISSN

Volume Title

Publisher

Universidade Federal de Juiz de Fora

DOI

Abstract

Background: Despite recent advances in the treatment of patients with Crohn's disease (CD), occlusive and subocclusive symptoms observed in the presence of clinically significant stenosis remains a challenging clinical problem. In inflammatory bowel diseases (IBD), the identification of factors associated with reduced risk of surgery in this context is important. Materials and methods: In this retrospective study, we evaluated the possible predictive factors, including inflammatory markers associated with reduced need for surgical intervention in patients with CD who presented the first episode of clinically solved subocclusion and treated subsequently with azathioprine (AZA) for three years. Results: Thirty-six patients with subocclusive CD were included, of these, 24 has not required bowel resection. No demographic or clinical data associated with the response to AZA. Only C reactive protein (CRP) was correlated with the effectiveness of AZA. For each increase of 1 mg CRP, there was a reduction of surgery risk in 8% (RR 0.92, CI 0.86-0.98; P = 0.008). The CRP group> 6 (elevated) had 81% of surgery risk reduction compared to PCR group <6 (OR 0.19 CI 0.05-0.64; P = 0.008). Conclusions: Patients with elevated CRP has a lower rate of surgery in the medium and long term during therapy with AZA. CRP can identify patients with inflammatory stenosis and responsive to clinical treatment.

Description

Citation

Endorsement

Review

Supplemented By

Referenced By

Rights and licensing

Acesso Aberto